{"name":"Olympus Corporation","slug":"olympus","ticker":"7733.T","exchange":"TSE","domain":"olympus-global.com","description":"Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation.","hq":"Tokyo, Japan","founded":1919,"employees":"29297","ceo":"Stefan Kaufmann","sector":"Medical Devices / Endoscopy","stockPrice":1602,"stockChange":39,"stockChangePercent":2.5,"marketCap":"$1.8T","metrics":{"revenue":987506016256,"revenueGrowth":3.9,"grossMargin":66.2,"rdSpend":0,"netIncome":84799995904,"cash":169464004608,"dividendYield":1.92,"peRatio":18.6,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"EndoHarmonics patent cliff ($100M at risk)","drug":"EndoHarmonics","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-09-01","type":"earnings","headline":"Olympus Reports Strong Q2 FY2023 Earnings","summary":"Olympus Corporation reported strong earnings for the second quarter of fiscal year 2023, driven by growth in the endoscopy segment.","drugName":"","sentiment":"positive"},{"date":"2022-08-01","type":"deal","headline":"Olympus Acquires Medtronic's Surgical Robotics Business","summary":"Olympus Corporation acquired Medtronic's surgical robotics business, expanding its presence in the surgical robotics market.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE9IZGZXemlxMW9PV3hoblhQT00wVnFjY29LUHBYMUVqQ2xWd0t2dTJtTThzRmJrSi0zVWpvOUFTbUx1bkN1VEJRMktDMmtPMnV3SUFGZA?oc=5","date":"2026-04-02","type":"pipeline","source":"Yahoo Finance Australia","summary":"Terumo Corporation (4543.T) stock price, news, quote and history - Yahoo Finance Australia","headline":"Terumo Corporation (4543.T) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOb0IzT3lSaDZnZkJrdllmY0lYX2I5bXFxbFczSTJ3bGRPN05pcFZjaG5fMmRYYmdvNVAzRFF6YkFpTEhTajFYR2NDWXdWclBRM2dYU2VDc05iNkFkUEFoSl9ES2d2WUJEZ3VHZ0NxUFhPUXZGX1U1anJKbzJEd3JOY0VvdFVieTZESXRReFV3NkFaQmVGZnQ2VmRnNEhCVk5DeWdtUEJMcmUyZDltdWJva2RIYklzRWcySDZFTzhNXzVKMTgyeFFrdkR1Y1F4dzFkdWVrQTd3?oc=5","date":"2024-10-28","type":"pipeline","source":"Reuters","summary":"Olympus CEO ousted after allegation of illegal drug purchase, shares slump - Reuters","headline":"Olympus CEO ousted after allegation of illegal drug purchase, shares slump","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1xY3FvYTJOOG03U2VuVS1sb3pSYk1CNzhTczhjejdXNzBtalduUGJMTEk1UkRUcmozY2RtTkFnQndvT050TjlLaksyUmhSZklQclViZg?oc=5","date":"2019-08-19","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Nipro Corporation (8086.T) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Nipro Corporation (8086.T) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQVDlqR2JoYXNqSmJwbEN6VWUtQ2ljY0pxbzluVTB3dFlERHRUbmVVWnUwZnZBbVFHcWtiZ0R2SFFHVEFIMFY1dGFtODRpd1kxZnJXWVZIamJ4cDc1RlMwVmlmMzZ6Qy1vVUhDT2YxY3RFWExiOVA0WC1IWG9fTGY0RkhNMVNUZkE1ekJ4QmVmNTNDVUNNNS1vNkFuSjVneUNvWVR4bHdkVkdGUUZtQWRySVhpMHg2R3pnQU1TZllXdjE?oc=5","date":"2019-01-10","type":"pipeline","source":"Reuters","summary":"Japan's Olympus to propose board seat for activist investor ValueAct - Reuters","headline":"Japan's Olympus to propose board seat for activist investor ValueAct","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNQ1RIcGwyOXRabGYwYW96amw4SlNiazNrMTUtUk9INjJ2YU1JZV9keGgydTJ6NXVCRXBjZ01fVW82VXlxMWQyMFE3RnVLUDduRHdvTDB4bGFHUnc2TG9KT3dzb0gyVEdkQ3o1Z2k2QlQ0aTNCVVQ2eGFPQXRGUVltSmNJa1JicVNZVHZsanJURmpNY1NDMy13SlAwZUtOUER5VWo4UmpwdmFXM2F5QjFrNy1yYmZjYTFWS3FueXdn?oc=5","date":"2016-05-03","type":"pipeline","source":"Reuters","summary":"Secrecy, hierarchy haunt Japan corporate culture despite Abe's reforms - Reuters","headline":"Secrecy, hierarchy haunt Japan corporate culture despite Abe's reforms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNMG9VZlBNSmdDbFE3YUlLbDdQcnlVY0N6Umhic3RhVE1UUXZReWJiM0FnUmpnMFVHZV9rZXFJRnl3ODBVenB2b01iSGg5MGQtU2NzdW9fLVhPYzZ5TF9jS1ByOHBsd1VZbjR3bTloeGNCXzAwMjRQOWhpRmlKSnk2YTRUb040eV83bkNYZHlZcDFPSUdzdngzb2piUVRDTnFTbFVHVnhZU3c3YzM2UWE4cjVtREY?oc=5","date":"2011-12-05","type":"pipeline","source":"Reuters","summary":"Japan's Olympus faces moment of truth in accounting scandal - Reuters","headline":"Japan's Olympus faces moment of truth in accounting scandal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOcmczWHNlVTRzYlUtTXBmQVRkQ0ZVZVphSlp2dEEydVF0SHRTVGtjVFF2S2hsSXl3QlZMN19jLTQ5WjZ4MERBb0NDNVVVZTF5cGlkNC1keWhhdlVhTndNODFLQzB5ekFOWmJ3aVk4a1BpTVhhaS1WZklYYmVielJwb3JaeXgyU1BPQkpOOXBNbl9DX3B3Z2FhbnlJbk5yZVUzc3RJbmNVNGNHRUFvcEc4cDhGM24?oc=5","date":"2011-11-29","type":"pipeline","source":"Reuters","summary":"Japan's Olympus to review business structure amid scandal - Reuters","headline":"Japan's Olympus to review business structure amid scandal","sentiment":"neutral"}],"patents":[{"drugName":"EndoHarmonics","drugSlug":"endoharmonics","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Johnson & Johnson","Boston Scientific","Medtronic"],"therapeuticFocus":["Endoscopy","Surgical Instruments"],"financials":null,"yahoo":{"currentPrice":1602,"previousClose":1563,"fiftyTwoWeekHigh":2168,"fiftyTwoWeekLow":1302.5,"fiftyTwoWeekRange":"1302.5 - 2168.0","fiftyDayAverage":1585.06,"twoHundredDayAverage":1810.85,"beta":0.17,"enterpriseValue":1789324820480,"forwardPE":12.8,"priceToBook":2.28,"priceToSales":1.79,"enterpriseToRevenue":1.81,"enterpriseToEbitda":8.62,"pegRatio":3.61,"ebitda":207700000768,"ebitdaMargin":21,"freeCashflow":11210500096,"operatingCashflow":123499003904,"totalDebt":237821001728,"debtToEquity":30.8,"currentRatio":1.63,"returnOnAssets":6.1,"returnOnEquity":11.2,"analystRating":"","recommendationKey":"none","numberOfAnalysts":13,"targetMeanPrice":1819.23,"targetHighPrice":2300,"targetLowPrice":1500,"dividendRate":30,"payoutRatio":0.23,"fiveYearAvgDividendYield":0.83,"exDividendDate":1774828800,"insiderHeldPercent":4.3,"institutionHeldPercent":59.9,"sharesOutstanding":1101067096,"floatShares":1079232935,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":86.28,"epsForward":125.64,"revenuePerShare":882.92,"bookValue":702.36,"officers":[{"age":54,"name":"Mr. Neil Boyden Tanner","title":"Executive Officer & Global General Counsel"},{"age":60,"name":"Mr. Frank  Drewalowski","title":"Senior advisor to CEO"},{"age":50,"name":"Ms. Gabriela  Kaynor","title":"Executive Officer & Chief Strategy Officer"},{"age":55,"name":"Shkolnik  Boris","title":"Executive Officer & Chief Quality Officer"},{"age":61,"name":"Mr. John  de Csepel","title":"Executive Officer & Chief Medical Officer"},{"age":63,"name":"Mr. Robert John White","title":"Representative Executive Officer, President, CEO & Director"},{"age":48,"name":"Mr. Michael  Parenti","title":"CFO & Executive Officer"},{"age":null,"name":"Takayuki  Aoyagi","title":"Vice President of Accounting"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.olympus.co.jp","phone":"81 42 642 2111"}}